Format

Send to:

Choose Destination
See comment in PubMed Commons below
Int J Tryptophan Res. 2010;3:157-67. Epub 2010 Aug 25.

Understanding the roles of the kynurenine pathway in multiple sclerosis progression.

Author information

  • 1Department of Pharmacology, School of Medical Sciences, University of New South Wales, Sydney 2052, Australia.

Abstract

The kynurenine pathway (KP) is a major degradative pathway of tryptophan ultimately leading to the production of nicotinamide adenine dinucleotide (NAD(+)) and is also one of the major regulatory mechanisms of the immune response. The KP is known to be involved in several neuroinflammatory disorders including Alzheimer's disease, amyotrophic lateral sclerosis, AIDS dementia complex, Parkinson's disease, schizophrenia, Huntington's disease and brain tumours. However, the KP remains a relatively new topic for the field of multiple sclerosis (MS). Over the last 2-3 years, some evidence has progressively emerged suggesting that the KP is likely to be involved in the pathogenesis of autoimmune diseases especially MS. Some KP modulators are already in clinical trials for other inflammatory diseases and would potentially provide a new and important therapeutic strategy for MS patients. This review summarizes the known relationships between the KP and MS.

KEYWORDS:

KP; MS; kynurenine pathway; multiple sclerosis; pathogenesis

PMID:
22084596
[PubMed]
PMCID:
PMC3195238
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Libertas Academica Icon for PubMed Central
    Loading ...
    Write to the Help Desk